‹ Library
FOXO4-DRI
Longevity & Anti-AgingResearch Use Only
Also known as: FOXO4 D-Retro-Inverso peptide, Proxofim
FOXO4-DRI is a synthetic D-retro-inverso peptide studied in preliminary research for its proposed role in senolytics, the selective clearance of senescent cells. It is designed to interfere with the FOXO4-p53 interaction and has been examined primarily in laboratory and animal models. This entry is educational and research-use-only, not medical advice.
Typical range (research)
No established human dose; referenced only in preclinical research protocols
Half-life
Not well characterized
Route
Subcutaneous / intraperitoneal (research)
Common use
Longevity / senescent-cell (senolytic) research
Common vial sizes
10 mg
Storage
Store lyophilized powder frozen and protected from light; once reconstituted, refrigerate and use promptly
Regulatory note: Not approved as a drug in Canada or the US; research-use-only and studied only in preclinical settings.
Calculate a dose →Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.